Search Results - "Sawyer, Lynette"
-
1
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Published in Transfusion (Philadelphia, Pa.) (01-07-2006)“…BACKGROUND: The INTERCEPT Blood System, a photochemical treatment (PCT) process, has been developed to inactivate pathogens in platelet concen‐trates. These…”
Get full text
Journal Article -
2
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Published in Science (American Association for the Advancement of Science) (11-11-1994)“…The ability of antibodies to neutralize diverse primary isolates of human immunodeficiency virus-type 1 in vitro has been questioned, with implications for the…”
Get full text
Journal Article -
3
-
4
Postexposure Immunoprophylaxis of Primary Isolates by an Antibody to HIV Receptor Complex
Published in Proceedings of the National Academy of Sciences - PNAS (31-08-1999)“…mAb B4 is a monoclonal antibody directed against HIV receptor complex. The antibody had broad neutralizing activity against HIV and provided postexposure…”
Get full text
Journal Article -
5
Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light
Published in The American journal of tropical medicine and hygiene (01-06-2013)“…Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that recently re-emerged in Africa and rapidly spread into countries of the Indian Ocean basin and…”
Get full text
Journal Article -
6
Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components
Published in Transfusion (Philadelphia, Pa.) (01-08-2008)“…BACKGROUND: Transfusion‐transmitted cases of malaria and babesiosis have been well documented. Current efforts to screen out contaminated blood products result…”
Get full text
Journal Article -
7
Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination
Published in Transfusion (Philadelphia, Pa.) (01-06-2007)“…BACKGROUND: The human erythrovirus B19 (B19) is a small (18‐ to 26‐nm) nonenveloped virus with a single‐stranded DNA genome of 5.6 kb. B19 is clinically…”
Get full text
Journal Article -
8
BLOOD COMPONENTS: Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Published in Transfusion (Philadelphia, Pa.) (01-07-2006)“…BACKGROUND:The INTERCEPT Blood System, a photochemical treatment (PCT) process, has been developed to inactivate pathogens in platelet concen-trates. These…”
Get full text
Journal Article -
9
Multicenter evaluation of the Bayer VERSANT™ HIV-1 RNA 3.0 assay: analytical and clinical performance
Published in Journal of clinical virology (01-08-2002)“…Background: The use of quantitative HIV-1 RNA assays is part of the standard of care for the management of HIV-1-infected individuals. Objective: The Bayer…”
Get full text
Journal Article -
10
In vitro Evolution of a Neutralizing Human Antibody to Human Immunodeficiency Virus Type 1 to Enhance Affinity and Broaden Strain Cross-Reactivity
Published in Proceedings of the National Academy of Sciences - PNAS (26-04-1994)“…A method is described that allows for the improvement of antibody affinity. This method, termed complementary-determining region (CDR) walking, does not…”
Get full text
Journal Article -
11
Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated
Published in Journal of Virology (01-03-1994)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
Passive Infusion of Immune Serum into Simian Immunodeficiency Virus-Infected Rhesus Macaques Undergoing a Rapid Disease Course Has Minimal Effect on Plasma Viremia
Published in Virology (New York, N.Y.) (25-04-2000)“…Antibody responses are often considered to play only a limited role in controlling viremia during chronic infections with human or simian immunodeficiency…”
Get full text
Journal Article -
13
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure
Published in The Journal of immunology (1950) (15-01-1995)“…As part of the goal of assembling a mixture of neutralizing human mAbs for possible prophylaxis and therapy of HIV-1 disease, we describe a strategy by which…”
Get full text
Journal Article -
14
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex
Published in Proceedings of the National Academy of Sciences - PNAS (31-08-1999)“…mAB B4 is a monoclonal antibody directed against HIV receptor complex. The antibody had broad neutralizating activity against HIV and provided postexposure…”
Get full text
Journal Article -
15
Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus
Published in Journal of acquired immune deficiency syndromes (1988) (01-03-1994)“…Although laboratory-adapted strains of human immunodeficiency virus (HIV) are generally highly sensitive to neutralization by HIV-positive patient sera, we…”
Get more information
Journal Article -
16
Mechanisms of the host cell effect on human immunodeficiency virus type 1 neutralization sensitivity
Published 01-01-1996“…Neutralizing antibody responses in vitro are a primary marker of host immunity and resistance to viral infection in vivo. However, studies of in vitro…”
Get full text
Dissertation